RE: Performance enhancement with selegiline

From: gts (gts_2000@yahoo.com)
Date: Mon Feb 17 2003 - 04:40:02 MST

  • Next message: Michael M. Butler: "CULTURE / WAR: More on Harold Pinter among others"

    As described in the abstract below, selegiline (deprenyl) also blocks
    the neurotoxic effects of MDMA (ecstasy). The mechanism by which
    selegiline protects the brain from ecstasy is relevant to any discussion
    of neuroprotection by selegiline.

    Hydrogen peroxide is a toxic by-product of the deamination of dopamine
    by MAO-B, one which can cause cell death by lipid peroxidation of cell
    membranes. Selegiline inhibits MAO-B, thus reducing lipid peroxidation.

    This is however just one of the suggested mechanisms by which selegiline
    is neuroprotective, and not the mechanism that I feel is most important.
    In addition to reducing hydrogen peroxide levels, selegiline
    up-regulates the production of SOD and catalase. Numerous experiments
    show life-extension benefits associated with increased levels of these
    two protective antioxidant enzymes.

    ABSTRACT
    The monoamine oxidase-B inhibitor L-deprenyl protects against
    3,4-methylenedioxymethamphetamine-induced lipid peroxidation and
    long-term serotonergic deficits
    by
    Sprague JE, Nichols DE
    Department of Pharmacology and Toxicology,
    School of Pharmacy and Pharmacal Sciences,
    Purdue University, West Lafayette, Indiana, USA.
    J Pharmacol Exp Ther 1995 May; 273(2): 667-73

    ABSTRACT
    3,4-Methylenedioxymethamphetamine (MDMA)-induced serotonergic
    neurotoxicity was assessed in the striatum, hippocampus and frontal
    cortex of rats by using [3H]paroxetine binding to label serotonin (5-HT)
    uptake sites and 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels as
    markers of serotonergic function. NMDA (40 mg/kg) induced a significant
    decrease in both [3H]paroxetine binding Bmax and 5-HT and 5-HIAA levels
    7 days after treatment. The monoamine oxidase-B inhibitor L-deprenyl (2
    mg/kg) administered 30 min before MDMA blocked these decreases. MDMA (40
    mg/kg) also maximally increased the formation of thiobarbituric acid
    reactive substances (an indicator of lipid peroxidation) 12 hr after
    treatment in all three brain regions studied. This increase in
    malondialdehyde formation was also blocked by pretreatment with
    L-deprenyl. Tryptophan hydroxylase (TPH) activity was also significantly
    reduced 18 hr after MDMA. L-Deprenyl reversed this decrease in TPH
    activity. Another experiment confirmed that a significant fraction of
    [3H]dopamine uptake into hippocampal synaptosomes was blocked by 500 nM
    fluoxetine, a selective 5-HT uptake inhibitor. These data suggest that
    the deamination by monoamine oxidase-B of excessive dopamine within the
    5-HT terminal generates hydrogen peroxide that may lead to membrane
    lipid peroxidation, and perhaps other oxidative insults, resulting in
    selective 5-HT terminal degeneration subsequent to MDMA treatment.



    This archive was generated by hypermail 2.1.5 : Mon Feb 17 2003 - 04:42:03 MST